Date: Saturday 09 Jul 2011
US markets were sent into decline by disappointing jobs data, and although prices finished well off their lowest levels, the week still ended on a dull note.
| Positive outcome in Bydureon test for Eli Lilly ... | 08-Jul-2011 | ShareCast |
| Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
| Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
| Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
| Genentech to Stop Selling Type of Growth Hormone | 02-Jun-2004 | LA Times |
| J&J, Alkermes Drug Rejected by FDA | 02-Jul-2002 | LA Times |
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 16.14 |
| Change Today | $ 0.19 |
| % Change | 1.19 % |
| 52 Week High | $19.52 |
| 52 Week Low | $13.88 |
| Volume | 1,042,883 |
| Shares Issued | 130.24m |
| Market Cap | $2,102.09m |
| Beta | 1.23 |
| RiskGrade | 180 |
| Time | Volume / Share Price |
| 16:00 | 22,582 @ $16.14 |
| 15:59 | 200 @ $16.15 |
| 15:59 | 100 @ $16.15 |
| 15:59 | 162 @ $16.15 |
| 15:59 | 100 @ $16.15 |
You are here: research